Bayforest Capital LTD Glaukos Corp Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Glaukos Corp stock. As of the latest transaction made, Bayforest Capital LTD holds 1,435 shares of GKOS stock, worth $124,644. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,435Holding current value
$124,644% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
344Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$698 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$519 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$179 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$168 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$127 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.13B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...